// App-Quantinova.ai

2548 : Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab

Researchers

Presenter

  • Laura C Coates

Principal Investigators

  • Proton Rahman

  • Eliofotisti Psaradellis

  • Emmanouil Rampakakis

  • Brendan Osborne

  • Allen J Lehman

  • Francois Nantel

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Rheumatology, St. Clar-s Mercy Hospital, St. John's, NF, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Medical Affairs, Janssen Inc., Toronto, ON, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • Ustekinumab

  • Infliximab

  • golimumab

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved